Paper412691
The structural basis of the blood-ocular barriers.
Raviola G. Exp Eye Res, 1977. Cited by 289 papers, by iCite.
Cite this record
ConductScience Library. The structural basis of the blood-ocular barriers. Papers, record 412691. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/412691
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Eye | Major topic |
| Animals | |
| Anterior Chamber | |
| Aqueous Humor | |
| Biological Transport | |
| Capillaries | |
| Capillary Permeability | |
| Choroid | |
| Ciliary Body | |
| Endothelium | |
| Freeze Fracturing | |
| Haplorhini | |
| Intercellular Junctions | |
| Iris | |
| Microscopy, Electron | |
| Pigment Epithelium of Eye | |
| Rabbits | |
| Retinal Vessels |
Source PubMed
Cited by81
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 289 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42282114 | Checkpoint inhibition and beyond: Precision immune engineering for the immune-privileged landscape of ocular malignancies. | Bioimpacts | 2026 | https://conductscience.org/library/papers/42282114 | PubMed |
| 42261356 | Bridging Preclinical and Clinical Gaps in Ocular Therapeutics: Hydrogel Drug Delivery and 3D Tissue Models. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/42261356 | PubMed |
| 41877771 | The Immunopathogenesis of uveitis. | Front Med (Lausanne) | 2026 | https://conductscience.org/library/papers/41877771 | PubMed |
| 41153322 | Cervical Oculopathy: The Cervical Spine Etiology of Visual Symptoms and Eye Diseases-A Hypothesis Exploring Mechanisms Linking the Neck and the Eye. | Diagnostics (Basel) | 2025 | https://conductscience.org/library/papers/41153322 | PubMed |
| 40718639 | Nanomedicine-Based Ophthalmic Drug Delivery Systems for the Treatment of Ocular Diseases. | Int J Nanomedicine | 2025 | https://conductscience.org/library/papers/40718639 | PubMed |
| 40293397 | A Model of the Mechanisms Underpinning Unconventional Aqueous Humor Outflow. | Invest Ophthalmol Vis Sci | 2025 | https://conductscience.org/library/papers/40293397 | PubMed |
| 39943986 | Nanoparticles in intraocular drug delivery. | Med Genet | 2025 | https://conductscience.org/library/papers/39943986 | PubMed |
| 38206586 | The anterior chamber of the eye technology and its anatomical, optical, and immunological bases. | Physiol Rev | 2024 | https://conductscience.org/library/papers/38206586 | PubMed |
| 37569464 | Ocular Vascular Diseases: From Retinal Immune Privilege to Inflammation. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37569464 | PubMed |
| 37530668 | Mass spectrometry in ocular drug research. | Mass Spectrom Rev | 2026 | https://conductscience.org/library/papers/37530668 | PubMed |
| 36965834 | Imaging ocular water inflow in the mouse with deuterium oxide MRI. | Magn Reson Imaging | 2023 | https://conductscience.org/library/papers/36965834 | PubMed |
| 36107200 | Nanomedicine and drug delivery to the retina: current status and implications for gene therapy. | Naunyn Schmiedebergs Arch Pharmacol | 2022 | https://conductscience.org/library/papers/36107200 | PubMed |
| 35729002 | Caveolar and non-Caveolar Caveolin-1 in ocular homeostasis and disease. | Prog Retin Eye Res | 2022 | https://conductscience.org/library/papers/35729002 | PubMed |
| 35283756 | Variability in Retinal Neuron Populations and Associated Variations in Mass Transport Systems of the Retina in Health and Aging. | Front Aging Neurosci | 2022 | https://conductscience.org/library/papers/35283756 | PubMed |
| 34769308 | Wnt Signaling in Inner Blood-Retinal Barrier Maintenance. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34769308 | PubMed |
| 34379187 | Possible roles of anti-type II collagen antibody and innate immunity in the development and progression of diabetic retinopathy. | Graefes Arch Clin Exp Ophthalmol | 2022 | https://conductscience.org/library/papers/34379187 | PubMed |
| 34043907 | Ophthalmic Sensors and Drug Delivery. | ACS Sens | 2021 | https://conductscience.org/library/papers/34043907 | PubMed |
| 32923627 | Wnt signaling activates MFSD2A to suppress vascular endothelial transcytosis and maintain blood-retinal barrier. | Sci Adv | 2020 | https://conductscience.org/library/papers/32923627 | PubMed |
| 32678110 | Rapid assessment of ocular drug delivery in a novel ex vivo corneal model. | Sci Rep | 2020 | https://conductscience.org/library/papers/32678110 | PubMed |
| 32179994 | The anterior eye chamber: entry of the natural excretion pathway of gadolinium contrast agents? | Eur Radiol | 2020 | https://conductscience.org/library/papers/32179994 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/412691
GET https://conductscience.org/api/papers/v1/412691/cited_by?page=2